Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (901-910 of 1,104) with videos related to

Pageof 111
Sort By:
Molecules (Basel, Switzerland)|August 27, 2021
Novel Anti-Melanogenic Compounds, (<i>Z</i>)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico InsightsHeejeong Choi, Il Young Ryu, Inkyu Choi, et al.
International Journal of Hematology|July 21, 2025
Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemiaSung-Soo Yoon, Chih Cheng Chen, Sung-Eun Lee, et al.
Transplantation and Cellular Therapy|November 28, 2024
Efficacy and Safety of Bispecific T-Cell Engagers in Relapsed/Refractory Multiple Myeloma: A Real-World Data-Based Case-Controlled StudySuein Choi, Ja Min Byun, Sung-Soo Park, et al.
The Journal of Biological Chemistry|February 16, 2011
Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cellsSoyoung Cheon, Ji Hyung Lee, Sunyoung Park, et al.
Medical Oncology (Northwood, London, England)|April 8, 2011
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patientsJoon Ho Moon, Sang Kyun Sohn, Shi Nae Kim, et al.
The Korean Journal of Internal Medicine|October 22, 2011
Acute lymphoblastic leukemia in elderly patients: a single institution's experienceDong-Yeop Shin, Inho Kim, Ki-Hwan Kim, et al.
Future Oncology (London, England)|March 14, 2020
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemiaPau Montesinos, Benjamin M Beckermann, Olivier Catalani, et al.
Journal of Korean Medical Science|August 16, 2005
A pilot study of bortezomib in Korean patients with relapsed or refractory myelomaKeun-Wook Lee, Tak Yun, Eun Kee Song, et al.
Journal of Medical Virology|December 4, 2025
Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir ProphylaxisJung Soo Son, Eun-Jeong Jeong, Hyeon Jae Jo, et al.
Molecules (Basel, Switzerland)|July 22, 2018
Analysis of the Active Constituents and Evaluation of the Biological Effects of <i>Quercus acuta</i> Thunb. (Fagaceae) ExtractsMi-Hyeon Kim, Dae-Hun Park, Min-Suk Bae, et al.
Pageof 111

Showing results (901-910 of 1,104) with videos related to

Sort By:
Pageof 111
Molecules (Basel, Switzerland)|August 27, 2021
Novel Anti-Melanogenic Compounds, (<i>Z</i>)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico InsightsHeejeong Choi, Il Young Ryu, Inkyu Choi, et al.
International Journal of Hematology|July 21, 2025
Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemiaSung-Soo Yoon, Chih Cheng Chen, Sung-Eun Lee, et al.
Transplantation and Cellular Therapy|November 28, 2024
Efficacy and Safety of Bispecific T-Cell Engagers in Relapsed/Refractory Multiple Myeloma: A Real-World Data-Based Case-Controlled StudySuein Choi, Ja Min Byun, Sung-Soo Park, et al.
The Journal of Biological Chemistry|February 16, 2011
Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cellsSoyoung Cheon, Ji Hyung Lee, Sunyoung Park, et al.
Medical Oncology (Northwood, London, England)|April 8, 2011
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patientsJoon Ho Moon, Sang Kyun Sohn, Shi Nae Kim, et al.
The Korean Journal of Internal Medicine|October 22, 2011
Acute lymphoblastic leukemia in elderly patients: a single institution's experienceDong-Yeop Shin, Inho Kim, Ki-Hwan Kim, et al.
Future Oncology (London, England)|March 14, 2020
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemiaPau Montesinos, Benjamin M Beckermann, Olivier Catalani, et al.
Journal of Korean Medical Science|August 16, 2005
A pilot study of bortezomib in Korean patients with relapsed or refractory myelomaKeun-Wook Lee, Tak Yun, Eun Kee Song, et al.
Journal of Medical Virology|December 4, 2025
Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir ProphylaxisJung Soo Son, Eun-Jeong Jeong, Hyeon Jae Jo, et al.
Molecules (Basel, Switzerland)|July 22, 2018
Analysis of the Active Constituents and Evaluation of the Biological Effects of <i>Quercus acuta</i> Thunb. (Fagaceae) ExtractsMi-Hyeon Kim, Dae-Hun Park, Min-Suk Bae, et al.
Pageof 111